Anti-TrkA (phospho Y496+Y674)+TrkB (phospho Y516+Y706)+TrkC (phospho Y516+Y709) antibody [RM1160]
- 20ul selling size
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Multiclonal TrkA phospho Y496 + Y674 antibody. Suitable for WB, Dot and reacts with Transfected cell lysate - Human, Human, Synthetic peptide - Human samples.
View Alternative Names
MTC, TRK, TRKA, High affinity nerve growth factor receptor, Neurotrophic tyrosine kinase receptor type 1, TRK1-transforming tyrosine kinase protein, Tropomyosin-related kinase A, Tyrosine kinase receptor, Tyrosine kinase receptor A, gp140trk, p140-TrkA, Trk-A, TRKB, BDNF/NT-3 growth factors receptor, GP145-TrkB, Neurotrophic tyrosine kinase receptor type 2, TrkB tyrosine kinase, Tropomyosin-related kinase B, Trk-B, TRKC, NT-3 growth factor receptor, GP145-TrkC, Neurotrophic tyrosine kinase receptor type 3, TrkC tyrosine kinase, Trk-C
- WB
Supplier Data
Western blot - Anti-TrkA (phospho Y496+Y674)+TrkB (phospho Y516+Y706)+TrkC (phospho Y516+Y709) antibody [RM1160] (AB322462)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The bands beneath the target band are likely to be degraded target fragments
In Western blot, Anti-Vinculin antibody [EPR8185] (ab129002) staining at 1/10000 dilution.
All lanes:
Western blot - Anti-TrkA (phospho Y496+Y674)+TrkB (phospho Y516+Y706)+TrkC (phospho Y516+Y709) antibody [RM1160] (ab322462) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
HeLa treated with 1mM pervanadate for 30 minutes, then replaced with 0.5mM H2O2 for 30 minutes, whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Untreated A431 (human epidermoid carcinoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg
Lane 4:
A431 reated with 100 uM pervanadate for 30 minutes whole cell lysate (untreated membrane) at 20 µg
Lane 5:
Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 6:
HeLa treated with 1mM pervanadate for 30 minutes, then replaced with 0.5mM H2O2 for 30 minutes, whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 7:
Untreated A431 (human epidermoid carcinoma epithelial cell) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Lane 8:
A431 reated with 100 uM pervanadate for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 92 kDa,124 kDa
false
Exposure time: 15s
- Dot
Supplier Data
Dot Blot - Anti-TrkA (phospho Y496+Y674)+TrkB (phospho Y516+Y706)+TrkC (phospho Y516+Y709) antibody [RM1160] (AB322462)
Dot blot analysis of TrkA (phospho Y496+Y674)+TrkB (phospho Y516+Y706)+TrkC (phospho Y516+Y709) using ab322462 at 1 : 1000 dilution (0.511 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Lane1 : Human TrkA (phospho Y496) peptide
Lane2 : Non-phospho TrKA control peptide for Lane 1
Lane3 : Human TrkA (phospho Y674) peptide
Lane4 : Human TrkA (phospho Y675) peptide
Lane5 : Non-phospho TrKA control peptide for Lane 3/4
Lane6 : Human TrkB (phospho Y516) peptide
Lane7 : Non-phospho TrKB control peptide for Lane 6
Lane8 : Human TrkB (phospho Y706) peptide
Lane9 : Human TrkB (phospho Y707) peptide
Lane10 : Non-phospho TrKB control peptide for Lane 8/9
Lane11 : Human TrkC (phospho Y516) peptide
Lane12 : Non-phospho TrKC control peptide for Lane 11
Lane13 : Human TrkC (phospho Y709) peptide
Lane14 : Human TrkC (phospho Y710) peptide
Lane15 : Non-phospho TrKC control peptide for Lane 13/14
Exposure time : 180 seconds.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Dot Blot - Anti-TrkA (phospho Y496+Y674)+TrkB (phospho Y516+Y706)+TrkC (phospho Y516+Y709) antibody [RM1160] (ab322462) at 1/1000 dilution
Lane 1:
Human TrkA (phospho Y496) peptide
Lane 2:
Non-phospho TrKA control peptide for Lane 1
Lane 3:
Human TrkA (phospho Y674) peptide
Lane 4:
Human TrkA (phospho Y675) peptide
Lane 5:
Non-phospho TrKA control peptide for Lane 3/4
Lane 6:
Human TrkB (phospho Y516) peptide
Lane 7:
Non-phospho TrKB control peptide for Lane 6
Lane 8:
Human TrkB (phospho Y706) peptide
Lane 9:
Human TrkB (phospho Y707) peptide
Lane 10:
Non-phospho TrKB control peptide for Lane 8/9
Lane 11:
Human TrkC (phospho Y516) peptide
Lane 12:
Non-phospho TrKC control peptide for Lane 11
Lane 13:
Human TrkC (phospho Y709) peptide
Lane 14:
Human TrkC (phospho Y710) peptide
Lane 15:
Non-phospho TrKC control peptide for Lane 13/14
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-TrkA (phospho Y496+Y674)+TrkB (phospho Y516+Y706)+TrkC (phospho Y516+Y709) antibody [RM1160] (AB322462)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
All lanes:
Western blot - Anti-TrkA (phospho Y496+Y674)+TrkB (phospho Y516+Y706)+TrkC (phospho Y516+Y709) antibody [RM1160] (ab322462) at 1/1000 dilution
Lane 1:
293T (human embryonic kidney epithelial cell) cells transfected with an empty vector containing a His-tag, whole cell lysate at 20 µg
Lane 2:
293T cells transfected with a human TrkA expression vector containing a His-tag, whole cell lysate at 20 µg
Lane 3:
293T cells transfected with a human TrkB expression vector containing a His-tag, whole cell lysate at 20 µg
Lane 4:
293T cells transfected with a human TrkC expression vector containing a His-tag, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 92 kDa,140 kDa,36 kDa
false
Exposure time: 15s
Reactivity data
Product details
What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:
- - The sensitivity of polyclonal antibodies by recognising multiple epitopes
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
View our range of recombinant multiclonal antibodies.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com